{"id":"standard-bismuth-quadruple","safety":{"commonSideEffects":[{"rate":"15-30","effect":"Nausea"},{"rate":"10-25","effect":"Diarrhea"},{"rate":"10-20","effect":"Abdominal discomfort"},{"rate":"5-15","effect":"Metallic taste"},{"rate":"null","effect":"Black stool discoloration"},{"rate":"5-10","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Bismuth quadruple therapy typically consists of bismuth subsalicylate or bismuth subcitrate, two antibiotics (commonly metronidazole and tetracycline), and a proton pump inhibitor or H2-receptor antagonist. Bismuth acts as a bactericidal agent against H. pylori while the antibiotics provide synergistic antimicrobial activity, and acid suppression creates an optimal environment for bacterial eradication and mucosal healing.","oneSentence":"Standard bismuth quadruple therapy combines bismuth salts with antibiotics and acid suppression to eradicate Helicobacter pylori infection through multiple mechanisms including direct bacterial toxicity and reduced antibiotic resistance.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:09:04.863Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Helicobacter pylori infection eradication in peptic ulcer disease"},{"name":"H. pylori-associated chronic gastritis"}]},"trialDetails":[{"nctId":"NCT06943794","phase":"NA","title":"Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-03-30","conditions":"Gastric (Stomach) Cancer","enrollment":4824},{"nctId":"NCT07104318","phase":"PHASE3","title":"Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Helicobacter Pylori","enrollment":360},{"nctId":"NCT05790525","phase":"PHASE4","title":"Effect of Oral Helicobacter Pylori Infection on the Efficacy of Gastroluminal Helicobacter Pylori Eradication Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2022-11-22","conditions":"Helicobacter Pylori","enrollment":200},{"nctId":"NCT06777732","phase":"EARLY_PHASE1","title":"The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-03","conditions":"Helicobacter Pylori Infection","enrollment":672},{"nctId":"NCT06168214","phase":"PHASE4","title":"Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2023-09-04","conditions":"the Eradication Rates of Helicobacter Pylori","enrollment":1404},{"nctId":"NCT05664685","phase":"PHASE4","title":"Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2022-10-17","conditions":"Helicobacter Pylori Infection","enrollment":127},{"nctId":"NCT06275204","phase":"","title":"H. Pylori Screen-and-treat Study in a Population of Young Adults","status":"RECRUITING","sponsor":"University of Latvia","startDate":"2024-03-04","conditions":"Gastric Cancer, H Pylori Infection, H Pylori Eradication","enrollment":6800},{"nctId":"NCT06143124","phase":"PHASE4","title":"Bismuth Quadruple Therapy Versus Standard Triple Therapy","status":"UNKNOWN","sponsor":"University Medical Centre Ljubljana","startDate":"2022-03-03","conditions":"Helicobacter Pylori Infection","enrollment":216},{"nctId":"NCT05850117","phase":"NA","title":"Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p","status":"UNKNOWN","sponsor":"Kaohsiung Medical University","startDate":"2020-02-10","conditions":"Helicobacter Pylori Eradication","enrollment":240},{"nctId":"NCT04660123","phase":"PHASE4","title":"A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-12-20","conditions":"Gastric Cancer, Helicobacter Pylori Infection, Bismuth","enrollment":959},{"nctId":"NCT05189444","phase":"NA","title":"The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori","status":"UNKNOWN","sponsor":"Huazhong University of Science and Technology","startDate":"2022-03-25","conditions":"Helicobacter Pylori Infection","enrollment":672},{"nctId":"NCT03688828","phase":"NA","title":"Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2018-11-11","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT04652284","phase":"PHASE3","title":"Effectiveness of Rifabutin for Treatment of Helicobacter Pylori","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2021-05-01","conditions":"Helicobacter Infections, Resistance Bacterial, Gastritis H Pylori","enrollment":300},{"nctId":"NCT02557932","phase":"PHASE3","title":"Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2015-09","conditions":"Helicobacter Pylori Infection, Family History of Stomach Cancer","enrollment":352},{"nctId":"NCT04034641","phase":"PHASE4","title":"Effect of Probiotics on Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Hangzhou Grand Biologic Pharmaceutical, Inc.","startDate":"2019-06-17","conditions":"Helicobacter Pylori Eradication","enrollment":238},{"nctId":"NCT01967329","phase":"PHASE4","title":"CANHelp Working Group Treatment Trials","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2008-11","conditions":"Helicobacter Pylori Infection","enrollment":338},{"nctId":"NCT03968302","phase":"PHASE2","title":"ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2018-06-01","conditions":"Helicobacter Pylori Infection","enrollment":196},{"nctId":"NCT01481844","phase":"PHASE3","title":"Sequential Therapy Versus Quadruple Therapy as Second Line Treatment After Failure of the Standard Triple Therapy for H Pylori Infection","status":"COMPLETED","sponsor":"Soroka University Medical Center","startDate":"2011-11","conditions":"Optimization of Second Line Treatment Protocol for H Pylori Eradication","enrollment":101}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standard bismuth quadruple","genericName":"Standard bismuth quadruple","companyName":"Xijing Hospital of Digestive Diseases","companyId":"xijing-hospital-of-digestive-diseases","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standard bismuth quadruple therapy combines bismuth salts with antibiotics and acid suppression to eradicate Helicobacter pylori infection through multiple mechanisms including direct bacterial toxicity and reduced antibiotic resistance. Used for Helicobacter pylori infection eradication in peptic ulcer disease, H. pylori-associated chronic gastritis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}